KM Research Hub
← 返回论文库
待处理 入排:待复核 图源:待检查 入排置信度 0.45

Horwitz SM, Scarisbrick JJ, Dummer R, et al. Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data. Blood Adv. 2021;5(23):5098-5106.

Blood Adv 8(9) 2243

PMID38743412
PMCIDPMC11116995
DOI10.1182/bloodadvances.2024012976
发表日期2024-05-14
入排依据:Title and metadata indicate a randomized Phase III oncology trial with a drug intervention, but the abstract is not provided and no time-to-event signal (OS, PFS, DFS, HR, Kaplan-Meier) is detected in the provided metadata. Cannot confirm human subjects or that this is an original result report (vs. update, erratum, etc.).
摘要

摘要

无摘要

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。